CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Evaluating the adverse events and tolerance of R-5280 in Mitigating Type 1 Diabetes in Newly Diagnosed Patients...
Phase 1
Rochester, Minnesota, United States and 2 other locations
This study is designed to evaluate the safety and effectiveness of endoscopic intestinal re-cellularization therapy in individuals with type 2 diabetes...
Rochester, Minnesota, United States and 45 other locations
are interested to evaluate the effect of BKR-017 (colon-targeted 500 mg butyrate tablets) as adjuvant therapy on metabolic control in type 1 diabetes...
Phase 1, Phase 2
Rochester, Minnesota, United States
Closed Loop system (HCL) in adult and pediatric patients with type 1 diabetes in the home setting. A diverse population of patients with typ...
Rochester, Minnesota, United States and 35 other locations
The goal of this clinical trial is to learn if the twiist insulin delivery system works to treat adults with insulin-treated type 2 diabetes....
Rochester, Minnesota, United States and 23 other locations
for endoscopic duodenal mucosal regeneration in patients with type 2 Diabetes inadequately controlled on 2-3 non-insulin glucose-lowering me...
Rochester, Minnesota, United States and 2 other locations
The study medicine will be investigated in participants with type 1 diabetes. The study will look at how well insulin icodec taken weekly co...
Phase 3
Rochester, Minnesota, United States and 169 other locations
fenofibrate is effective for reducing the onset of proliferative diabetic retinopathy (PDR) or and the results are adopted by the community ...
Phase 3
Rochester, Minnesota, United States and 62 other locations
This study is researching experimental drugs called trevogrumab and garetosmab (called "study drugs") in combination with another drug, semaglutide (...
Phase 2
Rochester, Minnesota, United States and 65 other locations
This is an open-label extension study to evaluate the long-term safety of relacorilant in patients with endogenous Cushing syndrome who successfully...
Phase 2
Rochester, Minnesota, United States and 47 other locations
Clinical trials
Research sites
Resources
Legal